Algorithm-based management of complications after pancreatic resection

Affiliations

Comment

Eliza W Beal. Lancet. 2022.

. 2022 May 14;399(10338):1846-1847.

doi: 10.1016/S0140-6736(22)00626-2. Epub 2022 Apr 28.

¹ The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, OH 43210, USA. Electronic address: eliza.beal@osumc.edu.

No abstract available

Conflict of interest statement

I declare no competing interests.

Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label, nationwide, stepped-wedge cluster-randomised trial.
Smits FJ, Henry AC, Besselink MG, Busch OR, van Eijck CH, Arntz M, Bollen TL, van Delden OM, van den Heuvel D, van der Leij C, van Lienden KP, Moelker A, Bonsing BA, Borel Rinkes IH, Bosscha K, van Dam RM, Derksen WJM, den Dulk M, Festen S, Groot Koerkamp B, de Haas RJ, Hagendoorn J, van der Harst E, de Hingh IH, Kazemier G, van der Kolk M, Liem M, Lips DJ, Luyer MD, de Meijer VE, Mieog JS, Nieuwenhuijs VB, Patijn GA, Te Riele WW, Roos D, Schreinemakers JM, Stommel MWJ, Wit F, Zonderhuis BA, Daamen LA, van Werkhoven CH, Molenaar IQ, van Santvoort HC; Dutch Pancreatic Cancer Group. Smits FJ, et al. Lancet. 2022 May 14;399(10338):1867-1875. doi: 10.1016/S0140-6736(22)00182-9. Epub 2022 Apr 28. Lancet. 2022. PMID: 35490691 Clinical Trial.